257 related articles for article (PubMed ID: 20647314)
1. Wilson disease at a single cell level: intracellular copper trafficking activates compartment-specific responses in hepatocytes.
Ralle M; Huster D; Vogt S; Schirrmeister W; Burkhead JL; Capps TR; Gray L; Lai B; Maryon E; Lutsenko S
J Biol Chem; 2010 Oct; 285(40):30875-83. PubMed ID: 20647314
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte GP73 expression in Wilson disease.
Wright LM; Huster D; Lutsenko S; Wrba F; Ferenci P; Fimmel CJ
J Hepatol; 2009 Sep; 51(3):557-64. PubMed ID: 19596473
[TBL] [Abstract][Full Text] [Related]
3. Modifying factors and phenotypic diversity in Wilson's disease.
Lutsenko S
Ann N Y Acad Sci; 2014 May; 1315():56-63. PubMed ID: 24702697
[TBL] [Abstract][Full Text] [Related]
4. Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B.
de Bie P; van de Sluis B; Burstein E; van de Berghe PV; Muller P; Berger R; Gitlin JD; Wijmenga C; Klomp LW
Gastroenterology; 2007 Oct; 133(4):1316-26. PubMed ID: 17919502
[TBL] [Abstract][Full Text] [Related]
5. Urinary copper elevation in a mouse model of Wilson's disease is a regulated process to specifically decrease the hepatic copper load.
Gray LW; Peng F; Molloy SA; Pendyala VS; Muchenditsi A; Muzik O; Lee J; Kaplan JH; Lutsenko S
PLoS One; 2012; 7(6):e38327. PubMed ID: 22802922
[TBL] [Abstract][Full Text] [Related]
6. Targeted inactivation of copper transporter Atp7b in hepatocytes causes liver steatosis and obesity in mice.
Muchenditsi A; Yang H; Hamilton JP; Koganti L; Housseau F; Aronov L; Fan H; Pierson H; Bhattacharjee A; Murphy R; Sears C; Potter J; Wooton-Kee CR; Lutsenko S
Am J Physiol Gastrointest Liver Physiol; 2017 Jul; 313(1):G39-G49. PubMed ID: 28428350
[TBL] [Abstract][Full Text] [Related]
7. Distinct phenotype of a Wilson disease mutation reveals a novel trafficking determinant in the copper transporter ATP7B.
Braiterman LT; Murthy A; Jayakanthan S; Nyasae L; Tzeng E; Gromadzka G; Woolf TB; Lutsenko S; Hubbard AL
Proc Natl Acad Sci U S A; 2014 Apr; 111(14):E1364-73. PubMed ID: 24706876
[TBL] [Abstract][Full Text] [Related]
8. Systemic deletion of Atp7b modifies the hepatocytes' response to copper overload in the mouse models of Wilson disease.
Muchenditsi A; Talbot CC; Gottlieb A; Yang H; Kang B; Boronina T; Cole R; Wang L; Dev S; Hamilton JP; Lutsenko S
Sci Rep; 2021 Mar; 11(1):5659. PubMed ID: 33707579
[TBL] [Abstract][Full Text] [Related]
9. A systems approach implicates nuclear receptor targeting in the Atp7b(-/-) mouse model of Wilson's disease.
Wilmarth PA; Short KK; Fiehn O; Lutsenko S; David LL; Burkhead JL
Metallomics; 2012 Jul; 4(7):660-8. PubMed ID: 22565294
[TBL] [Abstract][Full Text] [Related]
10. Wilson disease.
Harada M
Med Electron Microsc; 2002 Jun; 35(2):61-6. PubMed ID: 12181646
[TBL] [Abstract][Full Text] [Related]
11. Activation of liver X receptor/retinoid X receptor pathway ameliorates liver disease in Atp7B(-/-) (Wilson disease) mice.
Hamilton JP; Koganti L; Muchenditsi A; Pendyala VS; Huso D; Hankin J; Murphy RC; Huster D; Merle U; Mangels C; Yang N; Potter JJ; Mezey E; Lutsenko S
Hepatology; 2016 Jun; 63(6):1828-41. PubMed ID: 26679751
[TBL] [Abstract][Full Text] [Related]
12. A structural model of the copper ATPase ATP7B to facilitate analysis of Wilson disease-causing mutations and studies of the transport mechanism.
Schushan M; Bhattacharjee A; Ben-Tal N; Lutsenko S
Metallomics; 2012 Jul; 4(7):669-78. PubMed ID: 22692182
[TBL] [Abstract][Full Text] [Related]
13. Identification of p38 MAPK and JNK as new targets for correction of Wilson disease-causing ATP7B mutants.
Chesi G; Hegde RN; Iacobacci S; Concilli M; Parashuraman S; Festa BP; Polishchuk EV; Di Tullio G; Carissimo A; Montefusco S; Canetti D; Monti M; Amoresano A; Pucci P; van de Sluis B; Lutsenko S; Luini A; Polishchuk RS
Hepatology; 2016 Jun; 63(6):1842-59. PubMed ID: 26660341
[TBL] [Abstract][Full Text] [Related]
14. Penicillamine increases free copper and enhances oxidative stress in the brain of toxic milk mice.
Chen DB; Feng L; Lin XP; Zhang W; Li FR; Liang XL; Li XH
PLoS One; 2012; 7(5):e37709. PubMed ID: 22629446
[TBL] [Abstract][Full Text] [Related]
15. Intracellular targeting of copper-transporting ATPase ATP7A in a normal and Atp7b-/- kidney.
Linz R; Barnes NL; Zimnicka AM; Kaplan JH; Eipper B; Lutsenko S
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F53-61. PubMed ID: 17928409
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis and drug response to zinc and D-penicillamine in stable ATP7B mutant hepatic cell lines.
Chandhok G; Horvath J; Aggarwal A; Bhatt M; Zibert A; Schmidt HH
World J Gastroenterol; 2016 Apr; 22(16):4109-19. PubMed ID: 27122662
[TBL] [Abstract][Full Text] [Related]
17. Structural and metabolic changes in Atp7b-/- mouse liver and potential for new interventions in Wilson's disease.
Huster D
Ann N Y Acad Sci; 2014 May; 1315():37-44. PubMed ID: 24697742
[TBL] [Abstract][Full Text] [Related]
18. Restoration of copper metabolism and rescue of hepatic abnormalities in LEC rats, an animal model of Wilson disease, by expression of human ATP7B gene.
Meng Y; Miyoshi I; Hirabayashi M; Su M; Mototani Y; Okamura T; Terada K; Ueda M; Enomoto K; Sugiyama T; Kasai N
Biochim Biophys Acta; 2004 Nov; 1690(3):208-19. PubMed ID: 15511628
[TBL] [Abstract][Full Text] [Related]
19. Early gestational gene transfer with targeted ATP7B expression in the liver improves phenotype in a murine model of Wilson's disease.
Roybal JL; Endo M; Radu A; Gray L; Todorow CA; Zoltick PW; Lutsenko S; Flake AW
Gene Ther; 2012 Nov; 19(11):1085-94. PubMed ID: 22158007
[TBL] [Abstract][Full Text] [Related]
20. Hepatic copper-transporting ATPase ATP7B: function and inactivation at the molecular and cellular level.
Bartee MY; Lutsenko S
Biometals; 2007 Jun; 20(3-4):627-37. PubMed ID: 17268820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
